Table 1.
Allele(s) and genotype | No. (%) of subjects in the population |
|
---|---|---|
HIV-1 negative (n = 29) | HIV-1 positive (n = 52) | |
KIR2DL2 and KIR2DL3 | ||
KIR2DL2/KIR2DL2 | 3 (13) | 6 (12) |
KIR2DL2/KIR2DL3 | 9 (39) | 16 (33) |
KIR2DL3/KIR2DL3 | 11 (48) | 27 (55) |
KIR3DL1 | ||
KIR3DL1/KIR3DL1 | 21 (88) | 45 (90) |
KIR3DL1/KIR3DS1 | 2 (8) | 4 (8) |
KIR3DS1/KIR3DS1 | 1 (4) | 1 (2) |
HLA-A | ||
Bw4−/Bw4− | 23 (85) | 39 (76) |
Bw4+/Bw4− | 4 (15) | 12 (24) |
Bw4+/Bw4+ | 0 (0) | 0 (0) |
HLA-B | ||
Bw6/Bw6 | 5 (20) | 21 (40) |
Bw6/Bw4-80I | 11 (44) | 16 (31) |
Bw4-80I/Bw4-80I | 7 (28) | 10 (19) |
Bw4-80T/Bw4-80I | 1 (4) | 1 (2) |
Bw6/Bw4-80T | 1 (4) | 3 (6) |
Bw4-80T/Bw4-80T | 0 (0) | 1 (2) |
HLA-C | ||
C1/C1 | 1 (4) | 12 (24) |
C1/C2 | 21 (81) | 21 (42) |
C2/C2 | 4 (15) | 17 (34) |